Prof. John Gallacher
Prof. John Gallacher
Scientific Advisor
John Gallacher is Professor of Cognitive Health at Oxford University, the Director of Dementias Platform UK, and the Director of the BrainWaves Study of Adolescent Wellbeing and Mental Health. An expert on brain health and the use of big data in medical research, Professor Gallacher holds a visiting professorship at Imperial College London and an honorary professorship at the University of Hong Kong. He is the Principal Investigator for the Caerphilly Prospective Study (CaPS).
Related
The Hidden Cost of Waiting to Rescue an At-Risk Clinical Trial
How sponsors can recognize material underperformance, diagnose root causes, and select the least disruptive path to recovery. Clinical trials rarely move from “on track” to “in crisis” overnight. Warning signs usually emerge gradually: si...
ESC 2026 Takeaways: Precision Prevention, Smarter Risk Assessment, and the Evolving Future of Cardiovascular Trials
The P95 Julius Clinical team recently joined researchers, sponsors, clinicians, and industry leaders in Munich for ESC Congress 2026. Across scientific sessions, new clinical guidance, and industry discussions, several themes emerged that could in...
Parkinson’s Is Not One Disease. Why Are We Still Designing Trials as If It Is?
Real-world evidence (RWE) can help neuroscience sponsors account for disease heterogeneity, identify development risks earlier, and build more precise evidence strategies from Day 1.For decades, Parkinson’s disease has often been approached ...